<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02160548</url>
  </required_header>
  <id_info>
    <org_study_id>Medicine SOMCH</org_study_id>
    <nct_id>NCT02160548</nct_id>
  </id_info>
  <brief_title>Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen in OP Poisoning</brief_title>
  <acronym>SalbutamolOP</acronym>
  <official_title>Effect of Adding Nebulized Salbutamol to Intravenous Atropine and Oxygen During Resuscitation of OP Pesticide Poisoned Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sylhet M.A.G.Osmani Medical College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sylhet M.A.G.Osmani Medical College</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesize that salbutamol will speed removal of alveolar fluid compared to atropine
      alone in OP poisoned patients. We propose to compare the effect of two stat doses of
      nebulized salbutamol (2.5 mg; 5.0 mg), with nebulized saline placebo, in symptomatic patients
      receiving standard resuscitation with atropine, oxygen, and fluids after poisoning with OP
      pesticides. 25 patients will be randomised to each arm (total 75 patients). Primary outcome
      will be oxygen saturation's over the following 60 min during resuscitation. Secondary
      outcomes will include atropine dose administered, speed to stabilization, aspiration or
      pneumonia, intubation, tachydysrhythmias, and mortality. A positive outcome will result in
      design of a large definitive phase III study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pesticide self-poisoning kills over 300,000 people every year (1). Most deaths occur in rural
      Asia where widespread use of pesticides to boost food production allows easy access at
      stressful times. The WHO now recognizes pesticide poisoning to be the single most important
      global means of suicide (2) Amongst pesticides, organophosphorus (OP) and carbamate
      insecticides are of most concern, causing about 2/3 of deaths (1,3). These insecticides
      inhibit the enzyme acetylcholinesterase (AChE), producing an 'acute cholinergic crisis' with
      reduced consciousness, bradycardia, hypotension, and acute respiratory failure. On arrival at
      hospital, patients are resuscitated with atropine and, for OPs, an oxime AChE reactivator
      (4). Unfortunately, this treatment is often inadequate and many still die (5). A recent
      Bangladeshi RCT showed that rapid resuscitation of patients with atropine saves lives (6).
      This study compared a faster 'doubling dose' method of atropinisation with a standard bolus
      method during resuscitation. It reported quicker stabilisation and a 14% absolute reduction
      in mortality.

      Rationale: Atropine only stops production of fluid and does not speed its removal from the
      lung. Therefore a treatment that increases removal, to complement atropine-induced cessation
      of production, could reduce fluid in the lungs and speed return effective oxygen exchange. A
      single nebulised dose of the beta-adrenergic agonist salbutamol may increase removal since it
      increases alveolar fluid removal via the epithelial sodium channel. A pilot clinical study is
      required to test the hypothesis and to provide data for powering a large phase III RCT.

      Research question: Will addition of the beta-adrenergic agonist salbutamol to atropine during
      resuscitation improve oxygenation, reduce the need for atropine, and speed stabilisation?

      Objectives:General Objectives: To test the efficacy of salbutamol at increasing oxygenation
      and speeding resuscitation.

      Specific Objectives: To test whether salbutamol alters dose of atropine administered and
      incidence of tachydysrhythmias.

      Total duration of the study will be one year and all patients aged 12 years or older with
      clinical features of OP/carbamate poisoning requiring oxygen and atropine will be enrolled.
      The study will be done in three arms.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of oxygen saturation</measure>
    <time_frame>60 minutes</time_frame>
    <description>Improvement of oxygen saturation from the base line to normal level after adding nebulized salbutamol to regular I/V atropine and oxygen therapy.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate, respiratory rate and Blood pressure</measure>
    <time_frame>60 minutes</time_frame>
    <description>Settlement of heart rate, respiratory rate and blood pressure to normal range after adding salbutamol to regular management.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Atropine dose</measure>
    <time_frame>120 minutes</time_frame>
    <description>Requirement of total atropine dose until full atropinization (before put in to maintenance dose) after adding nebulized salbutamol</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Organophosphate Poisoning</condition>
  <arm_group>
    <arm_group_label>'Standard care'</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Standard care= Intravenous fluids, Oxygen by face mask, Intubation if necessary, Mechanical ventilation (Engstrom Pro by GE) if necessary, Cardiac monitor (Infunix IP4050), Atropine (anti-muscarinic drug; G-Atropine) by intravenous route, Pralidoxime (acetylcholinesterase reactivating oxime drug; PAM-A) by intravenous route.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>'Standard care+ 2.5 mg Salbutamol'</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard care+ 2.5 mg Salbutamol= Nebulized salbutamol (Ventolin respiratory solution) 2.5 mg stat and once only with standard care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>'Standard care+ 5 mg Salbutamol'</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard care+ 5 mg Salbutamol= Nebulized salbutamol (Ventolin respiratory solution) 5 mg stat and once only with standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard care</intervention_name>
    <description>Standard management for OP poisoning</description>
    <arm_group_label>'Standard care'</arm_group_label>
    <other_name>Intravenous fluids</other_name>
    <other_name>Intubation if necessary,</other_name>
    <other_name>Mechanical ventilation if necessary (Engstrom Pro)</other_name>
    <other_name>Atropine (anti-muscarinic; G-Atropine)</other_name>
    <other_name>Pralidoxime (acetylcholinesterase reactivating oxime; PAM-A)</other_name>
    <other_name>Oxygen by face mask by intravenous route,</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard care+ 2.5 mg Salbutamol</intervention_name>
    <description>Ventolin respiratory solution 2.5 mg</description>
    <arm_group_label>'Standard care+ 2.5 mg Salbutamol'</arm_group_label>
    <other_name>Ventolin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard care+ 5 mg Salbutamol</intervention_name>
    <description>Ventolin respiratory solution 5 mg</description>
    <arm_group_label>'Standard care+ 5 mg Salbutamol'</arm_group_label>
    <other_name>Ventolin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age 12 yrs or older

          -  clinical features of OP poisoning

          -  requiring oxygen and atropine and give consent

        Exclusion Criteria:

          -  age 11 yrs or younger

          -  no requirement for atropine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fazle R Chowdhury, FCPS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant, Medicine, Sylhet M.A.G.Osmani Medical Collge, Sylhet, Bangladesh</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Eddleston, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Clinical Toxicology, University of Edinburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sylhet M.A.G.Osmani Medical College Hospital</name>
      <address>
        <city>Sylhet</city>
        <zip>3100</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <reference>
    <citation>Abedin MJ, Sayeed AA, Basher A, Maude RJ, Hoque G, Faiz MA. Open-label randomized clinical trial of atropine bolus injection versus incremental boluses plus infusion for organophosphate poisoning in Bangladesh. J Med Toxicol. 2012 Jun;8(2):108-17. doi: 10.1007/s13181-012-0214-6.</citation>
    <PMID>22351300</PMID>
  </reference>
  <reference>
    <citation>Eddleston M, Buckley NA, Eyer P, Dawson AH. Management of acute organophosphorus pesticide poisoning. Lancet. 2008 Feb 16;371(9612):597-607. Review.</citation>
    <PMID>17706760</PMID>
  </reference>
  <reference>
    <citation>Gunnell D, Eddleston M, Phillips MR, Konradsen F. The global distribution of fatal pesticide self-poisoning: systematic review. BMC Public Health. 2007 Dec 21;7:357. Review.</citation>
    <PMID>18154668</PMID>
  </reference>
  <reference>
    <citation>Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. QJM. 2000 Nov;93(11):715-31. Review.</citation>
    <PMID>11077028</PMID>
  </reference>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2014</study_first_submitted>
  <study_first_submitted_qc>June 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>December 28, 2015</last_update_submitted>
  <last_update_submitted_qc>December 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sylhet M.A.G.Osmani Medical College</investigator_affiliation>
    <investigator_full_name>Dr. Fazle Rabbi Chowdhury</investigator_full_name>
    <investigator_title>Consultant, Medicine</investigator_title>
  </responsible_party>
  <keyword>Organophosphate, insectiside, Salbutamol, Atropine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Poisoning</mesh_term>
    <mesh_term>Organophosphate Poisoning</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Albuterol</mesh_term>
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Pralidoxime</mesh_term>
    <mesh_term>Muscarinic Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

